Favipiravir
FabiFlu Numero Uno In Indian Pharma Market, Show April Sales Data
Banking - Published date: .
With sales of Rs 352 crore in April, this brand alone accounted for over 2 per cent of the total domestic pharma market ... Read more
Glenmark's Antiviral Combination For Moderate Covid-19 Shows No Benefit
Banking - Published date: .
The trial's findings confirm that the addition of umifenovir does not show any incremental benefit in clinical outcomes,... Read more
Hetero Launches Pack Of Generic Covid-19 Drug Favipiravir At Rs 2,640
Banking - Published date: .
Drug firm Hetero on Friday said it has launched a pack of its generic oral antiviral drug-- Favivir 800/200-- for the tr... Read more
Jenburkt Pharma Launches Covid-19 Drug Favipiravir At Rs 39 Per Tablet
Banking - Published date: .
The company hopes that the easy accessibility and affordable price point of an effective treatment such as Favivent will... Read more
Hyderabad's Raghav Life Sciences Develops Favipiravir For Covid-19 Patients
Banking - Published date: .
Firm says it has been in talks with at least eight buyers, including a few overseas companies, to supply the anti-retrov... Read more
Strides Pharma Gets DGCI Approval To Test Potential Covid-19 Drug
Banking - Published date: .
Glenmark was the first Indian firm to get approval from regulator to conduct trials on Favipiravir tablets, which are ot... Read more